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Abstract
Background: The routine use of preoperative biliary drainage before pancreaticoduodenectomy (PD) remains
controversial. This observational retrospective study compared stented and non-stented patients undergoing PD to
assess any differences in post-operative morbidity and mortality.
Methods: A total of 180 consecutive patients who underwent PD and had intra-operative bile cultures performed
between January 2010 and February 2013 were retrospectively identified. All patients received peri-operative
intravenous antibiotic prophylaxis, primarily cefazolin.
Results: Overall incidence of post-operative surgical complications was 52.3 %, with no difference between stented
and non-stented patients (53.4 % vs. 51.1 %; p = 0.875). However, stented patients had a significantly higher
incidence of deep incisional surgical site infections (SSIs) (p = 0.038). In multivariate analysis, biliary stenting was
confirmed as a risk factor for deep incisional SSIs (p = 0.044). Significant associations were also observed for cardiac
disease (p = 0.010) and BMI ≥25 kg/m2 (p = 0.045). Enterococcus spp. were the most frequent bacterial isolates in bile
(74.5 %) and in drain fluid (69.1 %). In antimicrobial susceptibilty testing, all Enterococci isolates were cefazolin-resistant.
Conclusion: Given the increased risk of deep incisional SSIs, preoperative biliary stenting in patients underging PD
should be used only in selected patients. In stented patients, an antibiotic with anti-enterococcal activity should be
chosen for PD prophylaxis.
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Background
Obstructive jaundice is the most frequent clinical pres-
entation of a periampullary tumor (i.e., in the the pan-
creatic head, distal bile duct or the ampulla of Vater).
Preoperative biliary drainage has been widely used to
provisionally resolve the problem but its routine imple-
mentation has become controversial and its diagnostic
or therapeutic benefit is no longer clear [1]. It has been
argued that stenting patients with jaundice before pan-
creatic surgery may be beneficial [2], since pathological
changes associated with increased bilirubin (e.g., itching,
endotoxemia, bleeding problems, hepatic insufficiency)
[3] and the retention of bile salts (e.g., a negative chron-
otropic cardiac effect and increased sodium renal ex-
cretion, resulting in hypovolemia, hypotension and
decreased renal perfusion) [4] can compromise the
outcome of surgery. Moreover, on a practical level,
preoperative biliary drainage can be done at less spe-
cialized centers without the facility to conduct imme-
diate pancreatic surgery, allowing later scheduling of
surgery in a high-volume hospital [5–8]. Preoperative
biliary stenting also allows patients to be candidated
for neoadjuvant therapies [9].
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However, there is evidence that endoscopic and/or
percutaneuos biliary drainage increases the risk of bacter-
ial colonization of the bile, since biliary stenting disrupts
the mechanical barrier function of the Oddi’s sphincter
and predisposes to ascending infection from the duode-
num [10, 11]. Bile colonization has been associated with
increased incidence of infectious post-operative complica-
tions, which may worsen surgical morbidity and mortality
[12]. Some authors have reported a significantly greater
incidence of post-operative wound infections in stented
patients [13, 14], particularly after pancreaticoduodenect-
omy (PD) [4, 15].
This observational retrospective study compared stented
and non-stented patients undergoing PD to assess any dif-
ferences in post-operative morbidity and mortality. In
addition, intra-operative bile and abdominal drain fluid
cultures were microbiologically assessed, and the suscepti-
bility of bacterial isolates to antibiotics currently used for
preoperative short-term prophylaxis evaluated [16].
Methods
A prospectively collected database of patients who
underwent pancreatic surgery at the Humanitas Re-
search Hospital, Rozzano, Italy, between January 2010
and February 2013 was reviewed and 187 consecutive
patients who underwent PD for benign or malignant dis-
ease were identified. All patients provided written con-
sent and this retrospective study was approved by the
ethics committee of our center (Comitato Etico Indipen-
dente IRCCS Istituto Clinico Humanitas) the 7th of July
2015. Of these patients seven were excluded from the
analysis; five because technical failures resulted in intra-
operative bile cultures not being available and two be-
cause surgery on the biliary tree occurred before PD.
Demographic and clinical characteristics of patients were
reported, including the occurrence of previous cancers
and presence of co-morbidities (cardiac disease or dia-
betes mellitus).
All patients received peri-operative intravenous (IV)
antibiotic prophylaxis in accordance with Italian and
international guidelines on antimicrobial prophylaxis in
surgery [16, 17]. The majority received IV cefazolin 2 g
30 to 60 min before cutaneous incision with intra-
operative doses repeated every 3 h to a maximum of
four injections. An intra-operative bile specimen was
routinely taken before transection of the biliary tree and
sent immediately for microbiological evaluation (aerobic
bacteria and fungi). To minimize intra-peritoneal accu-
mulation of bile and reduce contamination of the surgi-
cal field, the transected common hepatic duct was
temporarily occluded until biliary-enteric continuity was
restored by end-to-side anastomosis. Moreover, the peri-
toneal cavity and wound, both the fascial and subcuta-
neuos planes, were throughly rinsed at the end of
surgery [18]. Superior mesenteric or portal venous resec-
tion was done in seven patients (3.9 %). Reconstruction
was performed by end-to-side double-layer pancreatico-
jejunostomy, when possible duct-to-mucosa. End-to-side
hepaticojejunostomy was carried out 10–15 cm distal to
the pancreatic anastomosis. A pylorus-preservation pro-
cedure was usually performed, and an end-to-side ante-
colic duodenojejunostomy was realized 30 cm distal to
the biliary-enteric anastomosis. At the end of the surgi-
cal procedure, two 12 mm Penrose type drainages
(Redax®, Poggio Rusco, MN, Italy), were placed to the
front and rear of the pancreaticojejunostomy with an-
other running under the biliary-enteric anastomosis.
Octreotide was routinely administrated during the post-
operative course.
From September 2010, a microbiological surveillance
culture was taken on the 5th post-operative day (POD5)
with fluid from the rear drain. This culture was repeated
if there was clinical evidence of intra-abdominal infection
i.e., a ‘sinister appearance’ of drained fluid or outflow from
a positioned percutaneous pig-tail tube (n = 23). Twenty-
four (13.3 %) patients lacked a POD5 culture from the rear
pancreatic drainage (operated on before September 2010,
n = 15; rear pancreatic drainage empty, n = 7; early death,
n = 2).
Post-operative morbidity, mortality (death within
30 days after day of hospital discharge), reintervention
and readmission rates were evaluated overall and for
stented and non-stented groups. Post-operative compli-
cations included pancreatic, biliary, duodenal/gastric and
lymphatic fistulas, abdominal abscess, delayed gastric
empting (DGE), wound infection, post-pancreatectomy
hemorrhage (PPH), pancreatitis, urinary tract infection,
sepsis and hospital-acquired pneumonia. Post-operative
pancreatic fistula (POPF), PPH and DGE were defined
according to International Study Group for Pancreatic
Surgery recommendations [19–21]. Biliary and lymph-
atic fistulas were defined by the presence of bile or
lymph, respectively, in surgical drains. The presence of
fluid collection on computed tomography (CT) was re-
quired to confirm intra-abdominal abscess. A diagnosis
of infection required fever as well as elevation of white
blood cell count and C-reactive protein. Wound infection
required purulent drainage from the surgical incision with
bedside opening of the wound. Wound infections were
further investigated using the definitions of surgical site
infections (SSIs) according to the Centers for Disease
Control and Prevention (CDC) [22] and Infection Diseases
Society of America (IDSA) guidelines [23]. Pancreatitis
was diagnosed if patients had abdominal pain, elevated
serum amylase level and CT signs. Urinary tract infection
was determined by a positive urine culture. Sepsis re-
quired ≥2 of fever >38.5 °C or <35 °C, heart rate >90 bpm,
respiratory rate >20 breaths per minute, and a confirmed
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infection. A diagnosis of pneumonia required radiographic
evidence of an infiltrate.
Microbiological cultures
Microbiological cultures of the bile and drainage fluid
were performed by conventional methods. In vitro anti-
microbial susceptibility of isolated organisms was done
in a local microbiology laboratory using the Phoenix 100
automated system (Becton Dickinson, Spark, MD, USA)
according to EUCAST interpretation criteria.
Statistical analysis
Demographic and clinical characteristics were described
as frequencies and proportions or as median and range.
Differences between stented and non-stented groups
were evaluated using the Chi-square test or the Fisher
exact test, when appropriate, for categorical data. Mean
and 95 % confidence intervals (95 % CIs) were calculated
to summarise continuous data and groups were compared
by t-test. The risk of deep incisional SSIs associated with a
range of demographic and clinical characteristics was ana-
lysed with univariate and multivariable logistic regression
models being used to estimate adjusted odds ratios (OR)
and corresponding 95 % CIs. In multivariate analysis we
consider only the characteristics statistically significant at
the univariate analysis. Statistical significance level was set
at 0.1 for univariate and 0.05 for multivariate analysis. All
p-values were two-sided. Statistical analysis was performed
using STATA v.13 software.
Results
Patients
Demographic and clinical characteristics of the 180 patients
are shown in Table 1.
Sixty-percent of patients were male (n = 108), median
age was 68 years (range 35–84) and median body mass
index (BMI) was 23.5 kg/m2 (range 15.2–36.1). Thirty-
seven patients (20.6 %) had a previous malignant neo-
plasm, 36 (20.0 %) had diabetes and 25 (13.9 %) had
cardiac disease.
A total of 102 patients at diagnosis (56.7 %) had ob-
structive jaundice with a median total bilirubin of
12.14 mg/dl. Of these, 89 underwent preoperative biliary
drainage; 75 (84.4 %) had a plastic stent, six (6.7 %) had
a metal stent, two (2.2 %) underwent endoscopic retro-
grade cholangiopancreatography (ERCP) with nasal-biliary
tubes and six (6.7 %) had a percutaneous transhepatic
catheter inserted. Median duration of stent placement in
the biliary tree was 35 days (range 8–393). Twenty-four
stented patients (27 %) needed more than one ERCP.
Fifty-nine patients (66.3 %) were referred to our institute
with the stent in place; we decided to drain the other 30
jaundiced patients, considering our elective surgery wait-
ing list, for the impossibility to plan their operation in a
short period of time. In thirteen cases favourable condi-
tions allow us to operate jaundice patients before stenting.
In our series there wasn’t any clinical selection bias on ic-
teric patients to drain.
The other 13 patients with jaundice (median total biliru-
bin 10.02 mg/dl) received no treatment. In total, 91 pa-
tients had no biliary stent; of these, six patients underwent
diagnostic ERCP while the other did not undergo any pre-
operative manoeuvre on the biliary tract. A total of 60 pa-
tients (33 %), of which 47 stented patients, still were icteric
(total bilirubin > 2.5 mg/dl) before surgery (Table 1).
The demographic and clinical characteristics of pa-
tients with and without pre-operative biliary stents were
similar, with the exception that post-operative diagnoses
revealed that significantly more of the stented group had
Table 1 Demographic and clinical characteristics
Characteristics All Non-stented patients Stented patients P-value
(N = 180) (N = 91, 50.6 %) (N = 89, 49.4 %)
Sex: Female/Male 72/108 40 (55.6)/51 (47.2) 32 (44.4)/57 (52.8) 0.346
Age: <68/≥68 (years) 85/95 44 (51.8)/47 (49.5) 41 (48.2)/48 (50.5) 0.875
Body mass index: <25/≥25 (kg/m2) 112/68 56 (50.0)/35 (51.5) 56 (50.0)/33 (48.5) 0.970
Previous neoplasia: No/Yes 143/37 74 (51.8)/17 (46.0) 69 (48.2)/20 (22.5) 0.657
Surgery for neoplasia: No/Yes 25/155 24 (96.0)/67 (43.2) 1 (4.0)/88 (56.8) <0.001
Diabetes: No/Yes 144/36 73 (50.7)/18 (50.0) 71 (49.3)/18 (50.0) 1.000
Preoperative jaundice: No/Yes 120/60 78 (65.0)/13 (21.7) 42 (35.0)/47 (78.3) <0.001
Cardiac disease: No/Yes 155/25 79 (51.0)/12 (48.0) 76 (49.0)/13 (52.0) 0.952
ASA physical status: 1-2/3-4 124/56 66 (53.2)/25 (44.6) 58 (46.8)/31 (55.4) 0.365
Previous antibiotic therapy: No/Yes 166/14 85 (51.2)/6 (42.9) 81 (48.8)/8 (57.1) 0.748
Preoperative CT or RT: No/Yes 170/10 88 (51.8)/3 (30.0) 82 (48.2)/7 (70.0) 0.210*
ASA American Society of Anesthesiologists, CT chemotherapy, RT radiotherapy, *Fisher exact test
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a malignant neoplasm (56.8 % vs 43.2 % of non-stented
patients; p < 0.001). Post-operative diagnoses are sum-
marized in Table 2.
Surgical characteristics
Mean estimated blood loss during surgery was 406.1 ml
(95 % CI: 337.5, 474.7) in all patients; 444.9 ml (95 % CI:
320.5, 569.4) in the stented group and 368.1 ml (95 %
CI: 306.1, 430.1) in the non-stented group (p = 0.274).
Mean operative time was 458.5 min (95 % CI: 448.1,
468.8), with similar mean durations in stented and non-
stented patients (454.8 min [95 % CI: 438.8, 470.8] vs.
462.1 min [95 % CI: 448.6, 475.6]; p = 0.489). A total of
141 patients (78.5 %) did not receive any blood transfu-
sion, with no difference between patients with and with-
out stents (p = 0.424). The mean calculated transfusion
volumes were 150.4 ml (95 % CI: 95.2, 205.7) for all pa-
tients; 117 ml (95 % CI: 60.7, 174.5) in the stented group
and 183.9 ml (95 % CI: 87.7, 280.1) in the non-stented
group (p = 0.274).
Post-operative outcomes
Overall, five patients died (2.8 %) during the follow-up
period, three in the stented group (3.4 %) (one due to
early septic shock and two because of multi-organ failure
following a type C fistula) and two in the non-stented
group (2.2 %) (one due to hemorrhagic stroke and one
due to aspiration pneumonia). In the post-operative
period, 14 patients (7.8 %) required reintervention, eight
(9.0 %) in the stented group and six (6.7 %) in the non-
stented group (p = 0.764). Reasons for reintervention
were early bleeding due to technical failure (n = 4,
28.6 %), pancreatic fistula type C (n = 3, 21.4 %), duo-
denal anastomotic dehiscence (n = 3, 21.4 %), biliary
anastomotic dehiscence, sepsis, occlusion, late bleeding
and fascial dehiscence (all n = 1, 7.1 %). Twelve patients
(6.7 %) were readmitted to our hospital after discharge:
three patients (3.4 %) in the stented group and nine
(9.9 %) in the non-stented group (p = 0.133).
The overall incidence of post-operative complications
was 61.7 % (n = 111), with no significant difference be-
tween stented and non-stented patients (65.2 % vs.
58.2 %; p = 0.422). Incidence of surgical post-operative
complications (i.e., pancreatic, biliary, duodenal and
lymphatic fistulas, abdominal abscess, DGE, wound
infection and PPH) was 52.3 % (n = 93) overall, 53.4 %
in stented patients and 51.1 % in non-stented patients
(p = 0.875). Of the 111 patients with complications, 67
(60.4 %) had Clavien scores ≤2 and 69 (38.3 %) had an
uneventful post-operative course. Post-operative com-
plications are summmarized in Table 3.
Types of post-operative complications were generally
similar between stented and non-stented patients. Pan-
creatic fistula, including clinically significant type B and
C fistula, occurred at a similar rate in stented and non-
stented patients. Wound infection was the only compli-
cation which showed a statistically significant difference
between groups, being reported in 28.4 % of stented
patients compared with 13.3 % of non-stented patients
(p < 0.022). Stented patients had a significantly higher
incidence of deep incisional SSIs (13.6 % vs 4.4 %; p =
0.038), whereas the incidence of superficial incisional
SSIs and organ/space SSIs was not significantly differ-
ent between the two groups (14.8 % vs 8.9 %; p = 0.325
and 31.5 % vs 22.2 %; p = 0.163, respectively) (Table 4).
Neither the presence of cholangitis and multiple pre-
operative ERCP, nor high duration of the stent placement
in the biliary tree affect the incidence of deep incisional
SSIs (p = 1.000, p = 1.000 and p = 0.532 respectively).
In jaundiced patiets we didn’t find any statistical dif-
ference for the incidence of deep SSIs between stented
(n= 88) and non stented (n= 13) (13.6 % vs 7.7 %; p = 1.000).
We also didn’t find any difference for deep incisional
SSIs in patients underwent ERCP without stenting (n = 6)
compared to non stented patients (n = 84) (16.7 % vs
3.6 %; p = 0.245). This results could be influenced by the
small size of the two subgroups analyzed.
The mean duration of preoperative time was 54.6 days
(95 % CI: 42.1,67.1) in the stented group and 32.0 days in
the non-stented group (95 % CI: 22.8,41.2), with statistical
significant difference between the two groups (p = 0.004).
However the waiting time for the surgical procedure
wasn’t statistically associated with the occurrence of deep
incisional SSIs (OR:1.00 95 % CI:1.00,1.01; p = 0.585).
In an univariate analysis, cardiac disease (p = 0.006), ASA
physical status 3–4 (p = 0.027) and BMI ≥25 kg/m2 (p =
0.043) were significantly associated with the occurrence of
deep incisional SSIs. No other associations between patient
characteristics and deep incisional SSIs were observed, nei-
ther for patients affected by neoplasia nor for jaundiced
patients before surgery (Table 5). Multivariate analysis
Table 2 Post-operative diagnosis of disease
Post-operative diagnosis N %
Malignant disease 155 100
Pancreatic ductal adenocarcinoma 75 48.4
Vater papilla adenocarcinoma 30 19.4
Invasive IPMN 17 11.0
Common bile duct adenocarcinoma 16 10.3
NET 13 8.4
Duodenal adenocarcinoma 3 1.9
Pancreatic liposarcoma 1 0.6
Benign disease 25 100
IPMN 13 52.0
Chronic pancreatitis 9 36.0
Duodenal/Vater papilla adenoma 3 12.0
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confirmed that the presence of a stent in the biliary tree sig-
nificantly increased the risk of deep incisional SSIs, with
stented patients at 3.47 times higher risk than non-stented
patients (95 % CI: 1.03, 11.67, p = 0.044). Cardiac disease
(OR 4.75, 95 % CI: 1.45, 15.53, p = 0.010) and BMI ≥25 kg/
m2 (OR 3.11, 95 % CI: 1.03, 9.42, p = 0.045) were also inde-
pendently significantly associated with an increased risk of
deep incisional SSIs in the multivariate model (Table 6).
The occurrence of deep incisional SSIs significantly pro-
longed mean post-operative length of hospital stay to
20.8 days (95 % CI: 14.9, 26.6) compared with 14.0 days
(95 % CI: 12.7, 15.3) in patients without deep incisional in-
fections (p = 0.003).
Microbiological assessment
A total of 154 patients (85.5 %) received prophylactic IV
cefazolin 2 g, seven (27 %) patients allergic to β-lactams
received IV clindamycin 600 mg and 19 (73 %) patients
received other antibiotic regimens (cephalosporins, peni-
cillins and/or fluoroquinolones), usually started at home
or at a different hospital.
Overall, 106 (58.9 %) intra-operative bile cultures were
positive, of which 81 were polymicrobial. Ninety-seven
patients (53.9 %) had a positive culture of surgical or
percutaneous positioned drainage fluid. Fifteen of 31 pa-
tients (48.4 %) with positive intra-operative bile culture
and pancreatic fistula revealed the same microrganisms
in both in biliary culture and in drainage fluid from the
rear of the pancreatic anastomosis on POD5. Microor-
ganisms isolated in bile and drain samples are reported
in Table 7. Enterococcus spp. (74.5 %) and the Gram-
negative Escherichia coli (36.8 %), Klebsiella spp. (34.9 %),
Enterobacter spp. (17.9 %) and Citrobacter spp. (9.4 %)
were the most frequently cultured bacteria in bile speci-
mens; these species were also present in drain fluid cul-
tures, although, with the exception of Enterobacter spp.,
Table 3 Postoperative complications stratified for the presence of biliary stent (Univariate analysis)
Complications All (N = 178) Non-stented (N = 90) Stented (N = 88) P value
N (% col) N (% col) N (% col)
Pancreatic fistula: No/Yes 127 (71.3)/51 (28.7) 64 (71.1)/26 (28.9) 63 (71.6)/25 (28.4) 1.000
A 19 (10.7) 10 (11.1) 9 (10.2) 0.995a
B + C 32 (18.0) 16 (17.8) 16 (18.2)
Biliary fistula: No/Yes 167 (93.8)/11 (6.2) 82 (91.1)/8 (8.9) 85 (96.6)/3 (3.4) 0.212b
Abdominal abscess: No/Yes 170 (95.5)/8 (4.5) 85 (94.4)/5 (5.6) 85 (96.6)/3 (3.4) 0.720b
Pneumonia: No/Yes 170 (95.5)/8 (4.5) 85 (94.4)/5 (5.6) 85 (96.6)/3 (3.4) 0.720b
Urinary tract infection: No/Yes 175 (98.3)/3 (1.7) 88 (97.8)/2 (2.2) 87 (98.9)/1 (1.1) 1.000b
Wound infection: No/Yes 141 (79.2)/37 (20.8) 78 (86.7)/12 (13.3) 63 (71.6)/25 (28.4) 0.022
Pancreatitis: No/Yes 175 (98.3)/3 (1.7) 87 (96.7)/3 (3.3) 88 (100)/0 (0.0) 0.246b
Sepsis: No/Yes 172 (96.1)/7 (3.9) 87 (96.7)/3 (3.3) 85 (95.5)/4 (4.5) 0.720b
Lymphatic fistula: No/Yes 168 (94.4)/10 (5.6) 87 (96.7)/3 (3.3) 81 (92.0)/7 (8.0) 0.209b
Post-pancreatectomy hemorrhage: No/Yes 153 (86.0)/25 (14.0) 76 (84.4)/14 (15.6) 77 (87.5)/11 (12.5) 0.711
A 14 (7.9) 9 (10.0) 5 (5.7) 0.958a
B 1 (0.5) 1 (1.1) 0 (0.0)
C 10 (5.6) 4 (4.4) 6 (6.8)
Duodenal/gastric fistula: No/Yes 175 (98.3)/3 (1.7) 89 (98.9)/1 (1.1) 86 (97.7)/2 (2.3) 0.619b
Delayed gastric emptying: No/Yes 173 (97.2)/5 (2.8) 88(97.8)/2 (2.2) 85 (96.6)/3 (3.4) 0.680b
aConsidering the subgroups
bFisher exact test
Two patients were excluded from analysis of post-operative complications because of early death (respectively 3rd and 5th post-operative day)
Table 4 Surgical site infections (SSIs) stratified for the presence of stent
Complications All Non-stented patients Stented patients P
valueN (% col) N (% col) N (% col)
SSI superficial: No/Yes 157 (88.2)/21 (11.8) 82 (91.1)/8 (8.9) 75 (85.2)/13 (14.8) 0.325
SSI deep: No/Yes 162 (91.0)/16 (9.0) 86 (95.6)/4 (4.4) 76 (86.4)/12 (13.6) 0.038
SSI organ/space: No/Yes 131 (73.2)/48 (26.8) 70 (77.8)/20 (22.2) 61 (68.5)/28 (31.5) 0.163
Bold data are statistical significant results
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less frequently than in bile. Gram-positive Staphylococci
spp. were more frequently isolated from drain fluid than
bile (26.8 % vs 4.7 %).
Candida spp. were isolated in 8.5 % of bile cultures,
but none of the 17 non-stented patients with positive
intra-operative biliary cultures had Candida colonization
(p = 0.349). Candida spp. were also more frequently cul-
tured from drain fluid than from bile (21.7 % vs 8.5 %).
High levels of resistance to cefazolin were observed,
with resistance to ampicillin-sulbactam also reported
Table 5 Deep SSIs distribution and univariate odds ratio stratified for principal clinical and demographic characteristics
Characteristics Deep SSIs Deep SSIs OR (95 % Confidence Interval) P value
No Yes

































































































aAge and Preoperative time were cathegorized considering the median value; /:not evaluable
Bold data are statistical significant results
Table 6 Odds ratio with their corresponding 95 % confidence
intervals for Multivariate final analyses
Characteristics OR CI 95 % P value
Stent Yes vs No 3.47 1.03;11.67 0.044
Cardiac disease Yes vs No 4.75 1.45;15.53 0.010
BMI ≥25 vs <25 Kg/m
2 3.11 1.03;9.42 0.045
Odds ratio with their corresponding 95 % confidence intervals for statistically
significant factors in the final multivariable model with variables confirming an
independent effect
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(Table 7). Extended-spectrum beta-lactamase (ESBL)-
producing Gram-negative bacteria, including E. Coli,
Enterobacter spp., Citrobacter spp., Klebsiella spp. and
Serratia marcescens were isolated in bile and drain cul-
tures: 80 patients had these bacteria present in bile cul-
tures, 17.5 % (n = 14) of which were ESBL-producing
strains.; 62 patients had these bacteria cultured in their
drain effluent, 32.2 % (n = 20) of which were ESBL-
producing strains.
All stented patients had positive bile cultures (n = 89,
100 %) compared with only 18.7 % (n = 17) of non-
stented patients (p < 0.001). Enterococcus spp. were signifi-
cantly more frequent in bile samples from stented patients
compared with non-stented patients with positive intra-
operative bile specimens (78.9 % vs 52.9 %; n = 0.026).
ESBL-positive strains were isolated only in intra-operative
bile cultures of stented patients.
We observed that all the PTBD patients (100 %) had
infected intraoperative bile and 4 (66.6 %) out of 6 pa-
tients with PTBD had their bile culture polymicrobic (3
germs each).
Discussion
The aim of this study was to assess the risk of post-op-
erative complications associated with preoperative biliary
stenting in patients undergoing pancreatic head resection.
Consistent with several previous studies, no differences in
mortality or overall morbidity were observed between
stented and non-stented patients [2, 9, 15, 24]. The mortal-
ity rate of 2.8 % is similar to that reported by other high-
volume pancreatic surgery centers [19]. Overall morbid-
ity was high (61.7 %), but only 39.6 % of patients had
serious complications (Clavien-Dindo classification
grade ≥3). Surgical morbidity was 52.3 %, which is also
consistent with that previously described [25–27].
The incidence of the most common post-operative
complications, including pancreatic fistula, biliary fistula
and abscess, were not significantly different between
stented and unstented groups. However, there was a sta-
tistically significant higher incidence of wound infection
in patients with stents compared with non-stented pa-
tients, a finding that has also been reported in other
studies. In a retrospective review of 567 patients under-
going PD without prior operative biliary bypass, stented
patients had a significantly higher incidence of wound
infection compared to patients without stents (10 % vs.
4 %; p = 0.02) [15]. A study of 212 patients presenting
with obstructive jaundice who subsequently underwent
PD reported that wound infection occurred in 8 % of pa-
tients with preoperative drainage but was not observed
in any non-stented patients (p = 0.039) [4]. Similarly,
Howard and colleagues reported that preoperative biliary
stenting increased the incidence of wound infection in a
study of 138 patients with obstructive jaundice (28.4 %
vs 13.3 %; p < 0.022) [28], while Limongelli et al. also
found wound infections significantly more frequent in
Table 7 Microbiological isolates in bile and drain fluid cultures of all patients
Microorganism Bile Draina
Patients CEF resb AMP resc P valued Patients CEF resb AMP resc P valued
N (%) % % N (%) (%) (%)
Enterococcus spp. 79 (74.5) 100 13.9 <0.001 67 (69.1) 100 28.9 <0.001
Escherichia coli 39 (36.8) 59 41 <0.113 26 (26.8) 76.9 57.7 <0.139
Klebsiella spp. 37 (34.9) 35.1 21.6 0.197 18 (18.6) 72.2 50 0.171
Enterobacter spp. 19 (17.9) 94.7 94.7 1.000 24 (24.7) 95.8 100 0.312
Citrobacter spp. 10 (9.4) 80 80 - 6 (6.2) 100 83.3 -
Hafnia alvei 7 (6.6) 71.4 100 - 3 (3.1) 100 100 -
Staphylococcus spp. 5 (4.7) 40 40 - 26 (26.8) 73.1 92.3 0.067
Pseudomonas aeruginosa 4 (3.8) 100 100 - 8 (8.3) 100 100 -
Aeromonas spp. 3 (2.8) 66.7 33.3 - 0 / / -
Serratia Marcescens 2 (1.9) 100 100 - 4 (4.1) 100 100 -
Streptococcus spp. 2 (1.9) 100 50 - 3 (3.1) 66.7 0 -
Morganella morganii 1 (0.9) 100 100 - 2 (2.1) 100 100 -
Proteus spp. 1 (0.9) 100 100 - 2 (2.1) 100 50 -
Candida spp. 9 (8.5) / / / 21 (21.7) / / /
aDrains with positive culture (surgical and percutaneous)
bCefazolin resistance
cAmpicillin-sulbactam resistance
dCorrelation between cefazolin resistance and Ampicillin-sulbactam resistance
- Data were not compared due to the small sample size;/Not evaluable
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stented compred with unstented patients [13]. In an-
other study of 300 consecutive PD patients, there was a
significant increase in wound infections in patients
treated by preoperative prosthetic biliary decompression
or surgical biliary bypass (n = 13) compared with non-
stented patients (n = 4; p = 0.022) [14]. However, in a
study conducted at the same centre 4 years later, the
presence of an endobiliary stent of any kind (metal or
plastic) was not associated with increased
PD-associated mortality or morbidity, including wound
infection [9]. The authors suggested that the difference in
superficial wound infection rates between the two studies
may have been related to differences in attentiveness to
wound irrigation and closure.
A trend to an higher rate of postoperative infection is
also observed, in our population, in patient that under-
went pancreaticoduodenectomy for neoplasia. This
could be explained by the higher rate of stented patients
among the ones that have a pancreatic neoplasia (56 %
vs 4 % p < 0.001).
To better understand the observed difference in
wound infection rate between stented and non-stented
patients in this study, we further analysed this complica-
tion using the CDC National Nosocomial Infection Sur-
veillance System (NNIS) standardized surveillance
criteria to define wound infections as superficial inci-
sional SSIs, involving only the skin and subcutaneous
tissue of the incision, or deep incisional SSIs involving
deep soft tissues of the incision (e.g., fascial and muscle
layers) [22]. No differences were observed beween
stented and non-stented groups in the incidence of
superficial wound infections, but stented patients had a
3.47-fold higher risk of developing deep incisional infec-
tions. The presence of a deep incisional SSI was associ-
ated with a significant increase in hospital length of stay,
which increased from two to almost three weeks. The
negative impact of SSIs on hospital length of stay and
healthcare costs following complex hepatopancreatobili-
ary operations has previously been reported [18]. More-
over, deep incisional SSIs increase the risk of immediate
or late fascial dehiscence. During follow-up of the 16 pa-
tients with deep incisional SSIs in this study, six (37.5 %)
developed an incisional hernia.
In multivariate analysis, cardiac disease and a BMI
≥25 kg/m2 were independent risk factors for the occur-
rence of deep incisional SSIs. It has long been known
that ‘past and present heart trouble’ significantly in-
creases the morbidity of patients undergoing PD, with
Gildorf and Spanos reporting in 1973 that 13 (54 %) of
24 patients with cardiac disease had major complication
or death after PD. [29] More recently, Lin at al. found
that a history of coronary artery disease correlated with
increased fistula rate in PD. [30] In the present study,
patients with cardiac disease had a 4.75 times higher risk
of developing post-operative deep incisional SSIs than
patients without cardiac problems. Opinions on the role
of obesity as a universal predictor of poor outcomes in
surgical patients vary [25]. In many type of surgery, in-
cluding orthopedic, gynecological, cardiac and colorec-
tal, obesity is an established risk factor for post-operative
morbidity [31, 32]. In pancreatic surgery, Su at al [33].
reported that BMI ≥25 kg/m2 was an independent pre-
dictor of serious post-operative infectious complications,
although not wound infection, after PD. However, a
multivariate analysis of 356 patients undergoing PD
showed that patients with BMI ≥30 kg/m2 and especially
those with BMI ≥35 kg/m2 were at significantly higher
risk of post-operative wound infection but not any other
complication [31]. While both cardiac disease and BMI
were independently associated with an increased risk of
developing a deep SSI, they did not negate the independ-
ent impact of stenting on the increased incidence of
deep SSIs.
All 89 patients with the biliary stent in place before
surgery had bacterial contamination of bile compared
with only 18.7 % of non-stented patients (p < 0.001).
Other authors have also reported bactibilia in stented
patients but at lower rates than we observed. Howard et
al. observed bactibilia in 80 % of stented patients versus
42 % of non-stented patients (p < 0.0001) [28], while
Jagannath and colleagues found 47 % of patients with
pre-operative biliary drainage had a positive bile culture
compared with 31 % of those without stents [34]. One
possible reason for the high percentage reported in this
study could be the period of time between positioning of
the biliary stent and surgery. The longer the biliary stent
is in place, the longer the reflux of intestinal bacteria
into the biliary tree and thus the risk of bacterial
colonization. In our cohort, 65 % of stented patients had
a stent in place for over 4 weeks and 38.2 % for over
6 weeks, since at least 4–6 weeks is necessary for full re-
covery of the metabolic abnormalities associated with
obstructive jaundice [35]. In addition, 24 (27 %) of the
89 stented patients in this study needed more than one
ERCP in order to change a plugged stent that was caus-
ing cholangitis while awaiting surgery. The need for
more than one endoscopic procedure for jaundice palli-
ation may also increase the risk of bactibilia.
Seventeen non-stented patients also had bacteria
present in bile. Bile culture is usually negative in healthy
persons [36] and patients with malignant biliary obstruc-
tion before biliary decompression, although other studies
published before and after the introduction of ERCP
have shown bactibilia in the absence of sphincterotomy
and biliary drainage and in patients with malignant ob-
structive jaundice [2, 34, 37]. Among our 17 non-stented
patients with bactibilia, only six had diagnostic ERCP be-
fore surgery and only one was jaundiced so it is difficult
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to explain how the positive bile cultures occurred in the
11 non-stented patients. However, this rate is lower than
observed in other studies and the presence of bactibilia
in 18.7 % of patients without a clear explanation sug-
gests intra-operative bile cultures are justified in all open
biliary tract procedures.
The other aim of this study was to evaluate the micro-
biology of bile and abdominal drainage fluid cultures
and to investigate how the two may be related. The micro-
organisms most commonly isolated in bile cultures were
Enterococcus spp. (74.5 %) and the Gram-negative bacteria
E. coli (36.8 %), Klebsiella spp. (34.9 %) and Enterobacter
spp (17.9 %). Dominant growth of Enterococci and Entero-
bacteriaceae was observed in both bile and drain fluid cul-
tures. These findings are consistent with other studies that
isolated similar bacteria in bile [10, 11, 27, 36, 38]. Polymi-
crobial colonization of bile was frequent, similar to many
previous observations [13, 28, 34, 39, 40]. However, unlike
our study, previous investigations have not always isolated
Candida spp. in bile cultures, although the presence of
Candida spp. in bile was previously observed by both
Howard et al. (21 % of patients) [28] and Karsten et al.
(10 %) [41]. While Howard and colleagues reported fungal
infection in both stented and non-stented patients,
Candida spp. were only isolated in bile samples from
stented patients (10.1 %) in our analysis. The importance
of Candida spp. in bile culture should not be overlooked,
especially given that, unlike anti-bacterial prophylaxis,
anti-fungal prophylaxis is often not administered [42].
Moreover, an increase of Candida spp., as well as
Staphylococci spp., was also observed in cultures from
drainage fluid cultures compared with bile. Recently
Kent at al [26]. isolated Candida spp. (10 %) as well as
Staphylococcus spp. (18 %) and other
Gram-positive and negative pathogens from infectious
complications of pancreatic resection. Hovewer, the
higher isolation of Candida spp. and Staphylococci spp.
in drain fluids could be due to the use of Penrose drain-
age and a possible contamination at the collection site.
A surveillance culture from fluid taken from the surgical
drain to the rear of the pancreatic anastomosis on POD5
was done in order for early identification of pathogens
in case of fistula, as well as to analyze if they were corre-
lated with bacteria isolated from intra-operative bile culture
[23]. Lygidakis et al. [43] demonstrated that microrganisms
isolated from bile in operated patients could be found in
the blood, infected wound exudate and intra-abdominal
abscesses of those patients with post-operative complica-
tions. Similarly, in a study of 161 patients undergoing PD,
Povoski et al. [44] found that microrganisms cultured
from bile were predictive of those cultured from subse-
quent intra-abdominal abscesses (100 % of patients), and
wound infection (69 % of patients). Howard et al. [28]
found that 42 % of infectious complications cultured the
same bacteria as bile. In this study, 48.4 % of patients with
positive intra-operative bile cultures and pancreatic fistula
had the same pathogens in bile and drain fluid at POD5, a
remarkably high rate considering that 74 patients (41.1 %)
had negative intra-operative bile cultures and 16 had no
evaluable POD5 drain fluid culture.
We also investigated the susceptibility of bacterial iso-
lates to cefazolin, usually administered peri-operatively,
and to ampicillin-sulbactam, another antibiotic often
recommended for prophylaxis in biliopancreatic surgery
[16, 17, 38]. Overall, 154 patients (85.5 %) received pre-
operative cefazolin. However, high levels of bacterial re-
sistance to this prophylactic regimen were observed. All
Enterococci isolates were resistant to cefazolin and suscep-
tibilty among other bacteria varied from zero to 65 %. En-
terococcus spp. were the bacteria most frequently cultured
in bile (74.5 % of patients) and in drain effluent (69.1 %)
and anti-enterococcal activity is essential for effective peri-
operative antibiotic therapy. As such, the choice of
prophylactic cefazolin does not apppear to have been ap-
propriate in this cohort. Of note, a higher incidence of En-
terococcus spp. isolated from preoperative bile cultures
approached statistical significance in the stented versus
unstented group (78.9 % vs 52.9 %; p = 0.026). Resistance
to ampicillin-sulbactam was lower, with 86 % of Entero-
coccus spp. isolates from bile samples and 71 % from drain
fluid effluent susceptible. Given this, ampicillin-sulbactam
might be the preferred antibiotic of first choice in PD
prophylactic regimens, rather than being considered as an
alternative to cefazolin. Moreover, considering the pres-
ence of 17.5 % ESBL Gram-negative bacteria in the bile of
stented patients, peri-operative IV prophylaxis should per-
haps involve a β-lactamase antibiotic active against Entero-
coccus spp. combined with an antibiotic active against
ESBL Gram-negative pathogens.
Conclusions
Given the increased risk of deep incisional SSIs and the
associated delay in discharging patients, preoperative bil-
iary stenting in patients undergoing pancreatic surgery
should be selectively rather than routinely used. Jaun-
diced patients candidate to surgery procedure had to be
drained if sepsis prevents operation. In icteric patients
unfit for surgery, addressed to neoadjuvant chemother-
apy, is necessary to positioning a biliary stent. Local hos-
pital factors, like elective surgical waiting list time,
presence of operative endoscopic facility, can influence
the decision-making of biliary drainage. It’s desirable to
develop guidelines to standardized treatment and care.
However, our results suggest that reducing the time pa-
tients wait for PD shoud be a higher priority. Patients
with cardiac disease or a high BMI are at risk of deep in-
cisional SSIs and require careful peri- and post-operative
monitoring. Adjunctive therapies aimed at reducing the
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risk of deep incisional SSI should be considered in these
patients. Pancreaticoduodenectomy requires antibiotic
prophylaxis to prevent post-operative infections of the
abdominal wall and intra-abdominal tissues: in patients
with biliary stents placed for obstructive jaundice and
preoperative infected bile an antimicrobial therapy with
anti-enterococcal activity should be chosen. Prospective
multicentre randomized studies are required to investi-
gate novel antibiotic prophylaxis regimens for PD.
Abbreviation
BMI: Body mass index; CDC: Center for disease control and prevention;
CIs: Confidence intervals; CT: Computed tomography; DGE: Delayed gastric
empting; ERCP: Endoscopic Retrograde Colangiopancreatography;
ESBL: Extended spectrum beta lactamase; EUCAST: European Committee on
Antimicrobial Susceptibility Testing; IDSA: Infection Diseases Society of
America; IV: intravenous; NNIS: National Nosocomial Infection Surveillance
System; OR: Odds ratios; PD: Pancreaticoduodenectomy; POD: Post-operative
day; POPF: Post-operative pancreatic fistula; PPH: PostPancreatectomy
hemorrhage; Spp: Species; SSI: Surgical site infections.
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